Article Text

07.11 Contribution of mthfr gene variants in lupus related subclinical atherosclerosis
  1. Maira Giannelou1,2,
  2. Andrianos Nezos3,
  3. Kyriaki Maselou4,
  4. Nikolaos Drakoulis5,
  5. Dimitrios Ioakeimidis2,
  6. Michael Koutsilieris3,
  7. Haralampos M Moutsopoulos1,
  8. Clio P Mavragani1,3
  1. 1Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens
  2. 2Department of Rheumatology, General Hospital of Athens “G.Gennimatas”
  3. 3Department of Physiology, School of Medicine, National and Kapodistrian University of Athens
  4. 4Department of Immunology, General Hospital of Athens, “G.Gennimatas”
  5. 5Department of Pharmaceutical Technology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece


Background Elevated concentrations of homocysteine have been previously identified as an independent risk factor for subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE). Given that heightened homocysteine levels are known to be strongly influenced by genetic factors, in the current study we investigated the contribution of functional polymorphisms of the gene encoding for the enzyme 5,10- methylenetetrahydrofolate reductase (MTHFRC677T and MTHFRA1298C) to atherosclerotic disease characterising SLE patients.

Materials and methods 138 consecutive SLE patients, according to the American College of Rheumatology (ACR) classification criteria were included in the study. All patients underwent ultrasound measurement of intima-media thickness scores (IMT) and detection of carotid and/or femoral (C/F) plaque. Clinical, haematological, serological, immunological characteristics, therapeutic regimens and classical risk factors for cardiovascular disease were recorded. Peripheral DNA samples from all SLE patients and 561 age/sex matched apparently healthy volunteers (HC) were genotyped by PCR-based assays for the detection of the MTHFR gene polymorphisms (C677T and A1298C). Data were analysed using univariate and multivariate models (SPSS 21.0) and SNPstats software.

Results While no difference in the prevalence of MTHFR677TT and MTHFR1298CC genotypes were detected between SLE patients and HC (19% vs 18.4% and 9.6% vs 11.9%, respectively, p-values>0.05 for both comparisons), MTHFR677TT variant was detected more frequently in SLE patients with plaque formation and high IMT scores compared to those without (26.8% vs 11.9%, p-value=0.004% and 29% vs 15%, p-value=0.02, respectively). A similar trend-though non significant- was observed between MTHFR1298CC variant with plaque formation/heightened IMT scores. The presence of either MTHFR1298CC or 677TT was identified as independent risk factor for both the formation of atherosclerotic plaque and high IMT scores [OR (95%) CI: 4.8 (1.00–23.7) and OR (95%) CI: 3.6 (1.00–13.8) respectively], following adjustment for potential cofounders.

Conclusions The independent association between the homozygous state for either MTHFR677TT or MTHFR1298CC genetic variants and subclinical atherosclerosis implies genetic influences as potential contributors to the increased burden of atherosclerotic disease characterising SLE.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.